WMT

117.01

+3.57%↑

78.79

+0.46%↑

140.43

-0.19%↓

176.18

+1.54%↑

PEP

142.52

+0.39%↑

WMT

117.01

+3.57%↑

78.79

+0.46%↑

140.43

-0.19%↓

176.18

+1.54%↑

PEP

142.52

+0.39%↑

WMT

117.01

+3.57%↑

78.79

+0.46%↑

140.43

-0.19%↓

176.18

+1.54%↑

PEP

142.52

+0.39%↑

WMT

117.01

+3.57%↑

78.79

+0.46%↑

140.43

-0.19%↓

176.18

+1.54%↑

PEP

142.52

+0.39%↑

WMT

117.01

+3.57%↑

78.79

+0.46%↑

140.43

-0.19%↓

176.18

+1.54%↑

PEP

142.52

+0.39%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

5.68 5.97

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

5.3

Max

5.77

Schlüsselkennzahlen
By Trading Economics
Einkommen	-8.9M -15M
Verkäufe	-7.9M 23M
Gewinnspanne	-64.588
Angestellte	382

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+37.53% upside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	20M 158M
Vorheriger Eröffnungskurs	-0.29
Vorheriger Schlusskurs	5.68

Nachrichtenstimmung

By Acuity

50%

70 / 131 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Juni 2026, 20:30 UTC

Ergebnisse

Palo Alto Networks 3Q Revenue Rises as Customers Beef Up Cyber Defenses

2. Juni 2026, 23:58 UTC

Market Talk

Australia's Consumer Sector Expected to Be Stung by Housing Downturn -- Market Talk

2. Juni 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

2. Juni 2026, 23:46 UTC

Market Talk

Nikkei May Rise as AI Demand Hopes Continue -- Market Talk

2. Juni 2026, 23:41 UTC

Market Talk

Oil Rises Amid Signs of U.S.-Iran Peace Talks Stalling -- Market Talk

2. Juni 2026, 23:01 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC Says Owner of Metro Petroleum Brand to Buy the 41 Sites

2. Juni 2026, 23:01 UTC

Akquisitionen, Fusionen, Übernahmen

ACCC Says Ampol Must Sell 41 Retail Fuel Sites to an Approved Purchaser

2. Juni 2026, 23:00 UTC

Akquisitionen, Fusionen, Übernahmen

Australia's Competition Regulator Approves Ampol's Purchase of EG Australia With Conditions

2. Juni 2026, 22:57 UTC

Market Talk

Australian Dollar Could Fall Following 1Q GDP Data -- Market Talk

2. Juni 2026, 22:50 UTC

Market Talk

Ulta Beauty Says TikTok Shop Will Provide 'Halo' Effect -- Market Talk

2. Juni 2026, 21:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. Juni 2026, 21:07 UTC

Market Talk

Tokenized Assets Need Access to Digital-Finance Plumbing -- Market Talk

2. Juni 2026, 21:00 UTC

Ergebnisse

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2. Juni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

2. Juni 2026, 20:46 UTC

Ergebnisse

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2. Juni 2026, 20:38 UTC

Ergebnisse

GitLab Stock Rises as the Software Company Raises Guidance on AI Business Momentum -- Barrons.com

2. Juni 2026, 20:21 UTC

Ergebnisse

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2. Juni 2026, 20:12 UTC

Ergebnisse

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks 3Q Product Rev $594M

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Sees FY26 Next-Generation Security ARR $8.9B-$8.95B

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Raises FY26 View To Adj EPS $3.77-Adj EPS $3.79 >PANW

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks 3Q Subscription and Support Rev $2.41B

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Sees FY26 Remaining Performance Obligation $20.9B-$21B

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Sees 4Q Rev $3.345B-$3.355B >PANW

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Sees 4Q Adj EPS 96c-Adj EPS 98c >PANW

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks on Track to Achieve 40% Adj Free Cash Flow Margin in FY28

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks Raises FY26 View To Rev $11.415B-$11.425B >PANW

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks 3Q Remaining Performance Obligation $18.4B

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks 3Q Adj EPS 85c >PANW

2. Juni 2026, 20:05 UTC

Ergebnisse

Palo Alto Networks 3Q Loss $177M >PANW

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Kursziel

By TipRanks

37.53% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD 37.53%

Hoch 9 USD

Tief 5 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Lifecore Biomedical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Stimmung

By Acuity

70 / 131 Ranking in Konsumgüter defensiv

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.